The co-occurrence of anthracosis with interstitial lung disease
Main Article Content
Keywords
Abstract
Objective：Anthracosis is defined as deposition of black pigments in the bronchial mucosa or lung parenchyma. The aim of this study was to investigate the clinical features of patients with coexisting anthracosis and interstitial lung diseases (ILDs).
Methods: A total of 335 ILDs patients who underwent bronchoscopy at the affiliated hospital of Qingdao University were included in our study. We enrolled 71 patients who diagnosed with anthracosis by bronchoscopy. The clinical presentations, radiographic features, and bronchoscopic findings of the patients were reviewed.
Results: Compared with the non-anthracosis group, biomass exposure (48, 67.6% vs. 153, 53.9%, p=0.041), the median pressure of carbon dioxide before six-minute test (42.00 mmHg vs. 40.00 mmHg, P=0.001), the mean peak expiratory flow (115.21±23.55 %predicted vs. 104.20±26.17%predicted, P=0.048), the mean level of triglyceride (1.79±1.27 mmol/L vs. 1.51±0.74 mmol/L，P=0.034) were significantly increased and the mean oxygen saturation after six-minute test (95.49±2.72% vs. 96.56±1.27%, P=0.028), the mean cardiac ejection fraction (61.22±2.07% vs.62.08±2.89%, P=0.019) were significantly decreased in the anthracosis group. However, we didn’t find significant difference between the two groups in lymph node calcification (p=0.620) and lymphadenectasis (p=0.440).
Conclusions: Biomass smoke is a risk factor for anthracosis. Anthracosis produce a bad effect on the oxygenation, cardiac function and lipid metabolism in ILDs patients. The ILDs patients should decrease the exposure of biomass.
References
(2) Stratton T. Case of anthracosis or black infiltration of the whole lungs. Edinb Med Surg J 1838; 49: 490–1.
(3) Amoli K. Anthracotic airways disease: report of 102 cases. Tanaffos 2009; 8(1): 14-22.
(4) Gunbatar H, Sertogullarindan B, Ozbay B, Avcu S, Bulut G, Kosem M. Chronic effects of environmental biomass smoke on lung histopathology in Turkish non-smoking women: a case series. Arh Hig Rada Toksikol 2012;63(3):357-65.
(5) Ramage JE Jr, Roggli VL, Bell DY, Piantadosi CA. Interstitial lung disease and domestic wood burning. Am Rev Respir Dis 1988;137(5):1229-32.
(6) Amoli K. Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke. Eur Respir J 1998; 11 (3): 659- 63.
(7) Pazoki M, Moazami Goodarzi H, Hashemi Taheri AP, Seifirad S, Nematollahi N, Paknejad O. Prevalence of Tuberculosis in Patients with Anthracosis: Study on 150 Subjects. Arch Iran Med. 2012; 15(3): 128 – 130.
(8) Samet M, Ayatollahi J, Aboutorabi A, Rahimian M, Shahcheraghi SH, Mirjalili SA. Comparison of samples obtained from bronchoscopy of patients with and without bronchial anthracosis for investigating the prevalence of Mycobacterium tuberculosis. Germs. 2015 Sep 1;5(3):78-82.
(9) Kim H, Cha SI, Shin KM, Lim JK, Oh S, Kim MJ, Lee YD, Kim M, Lee J, Kim CH. Clinical relevance of bronchial anthracofibrosis in patients with chronic obstructive pulmonary disease exacerbation. Tuberc Respir Dis (Seoul). 2014 Sep;77(3):124-31.
(10) Jamaati H, Bahrami N, Tabarsi P, Khosravi A, Kiani A, Abedini A, Ahmadi R, Sharifynia S, Mohamadnia A. Multi-Gene Expression in Anthracosis of the Lungs as One of the Risk Factors for Non-Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3129-3133.
(11) Kunal S, Pilaniya V, Shah A. Bronchial anthracofibrosis with interstitial lung disease: an association yet to be highlighted. BMJ Case Rep. 2016 Jan 11.
(12) Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Sep 1;198(5): e44-e68.
(13) Pilaniya V, Kunal S, Shah A. Occurrence of bronchial anthracofibrosis in respiratory symptomatics with exposure to biomass fuel smoke. Adv Respir Med. 2017;85(3):127-135.
(14) Goh NS, Desai SR, V eeraraghavan S et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008; 177:1248–1254.
(15) Ufuk F, Demirci M, Altinisik G. Quantitative computed tomography assessment for systemic sclerosis-related interstitial lung disease: comparison of different methods. Eur Radiol. 2020 Aug; 30(8):4369-4380.
(16) Sigari N, Mohammadi S. Anthracosis and anthracofibrosis. Saudi Med J 2009; 30(8): 1063-6.
(17) Mirsadraee M, Saeedi P. Anthracosis of lung; Evaluation of potential causes. Journal of bronchology& Interventional Pulmonology 2005; 12: 84-7.
(18) Mirsadraee M, Saffari A, Sarafraz Yazdi M, Meshkat M. Frequency of tuberculosis in anthracosis of the lung: a systematic review. Arch Iran Med 2013; 16 (11): 661- 4.
(19) Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med 2009; 103(5): 757- 65.
(20) Najafizadeh K, Zahirifard S, Mohammadi F, Farnia P, Shahghasempour S, Hasanzadeh N et al. Bronchial anthracofibrosis or anthracotic bronchitis. Tanaffos 2003; 2(8): 7-11
(21) Mirsadraee M. Anthracosis of the lungs: etiology, clinical manifestations and diagnosis: a review. Tanaffos. 2014;13(4):1-13.
(22) Mortazavi-Moghaddam SG, Saadatjoo SA. Bronchial anthracotic change in South Khorasan Province (Iran), emphasizing its association with tuberculosis. Iran J Med Sci 2014;39(5):418.
(23) Perez RL. Interstitial lung disease: causes, treatment, and prevention. Ethn Dis. 2005 Spring;15(2 Suppl 2): S45-8.
(24) Mirsadraee M, Asnashari A, Attaran D, Naghibi S.Mirsadraee S. Bronchial anthracosis, a new diagnosis for benign mass lesion of the lung. Tanaffos. 2013; 12(4):10-18.
(25) Halldorsdottir H, Thoroddsen A, Ingadottir B. Impact of technology-based patient education on modifiable cardiovascular risk factors of people with coronary heart disease: A systematic review. Patient Educ Couns. 2020 Oct;103(10):2018-2028.
(26) Panev NI, Zakharenkov VV, Epifantseva NN, TsaĭL V, Beloglazov ME, Safina VP, Gerasimova GA. Serum biochemistry data in association of atherosclerosis with pulmonary dust diseases. Med Tr Prom Ekol. 2006;(6):17-20. Russian.
(27) Wallwork RS, Colicino E, Zhong J, Kloog I, Coull BA, Vokonas P, et al. Ambient fine particulate matter, outdoor temperature, and risk of metabolic syndrome. American Journal of Epidemiology. 2017;185, 30-39.
(28) Zhang K, Wang H, He W, Chen G, Lu P, Xu R, et al. The association between ambient air pollution and blood lipids: A longitudinal study in Shijiazhuang, China. Science of The Total Environment.2020; 752, 141648.
(29) Xu MX, Ge CX, Qin YT, Gu TT, Lou DS, Li Q, et al. Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia. Free Radical Biology & Medicine.2019; 130, 542-556.
(30) Zhang Y, Ji X, Ku T, Li B, Li G, Sang N. Ambient fine particulate matter exposure induces cardiac functional injury and metabolite alterations in middle-aged female mice. Environmental Pollution.2019; 248, 121-132.
(31) Yang S, Chen R, Zhang L, Sun Q, Li R, Gu W, et al. Lipid metabolic adaption to long-term ambient PM(2.5) exposure in mice. Environmental Pollution.2021;269, 116193.
(32) Dutta A, Ray MR, Banerjee A. Systemic inflammatory changes and increased oxidative stress in rural Indian women cooking with biomass fuels. Toxicol Appl Pharmacol. 2012 Jun 15;261(3):255-62.
(33) Zakharenkov VV, Mikhailova NN, Zhdanova NN, Gorokhova LG, Zhukova AG. Experimental Study of the Mechanisms of Intracellular Defense in Cardiomyocytes Associated with Stages of Anthracosilicosis Development. Bull Exp Biol Med. 2015 Aug;159(4):431-4.
(34) Farina F, Sancini G, Longhin E, Mantecca P, Camatini M, Palestini P. Milan PM1 induces adverse effects on mice lungs and cardiovascular system. Biomed Res Int. 2013;2013:583513.
(35) Ocakli B, Acarturk E, Aksoy E, Gungor S, Ciyiltepe F, Oztas S, Ozmen I, Agca MC, Salturk C, Adiguzel N, Karakurt Z. The impact of exposure to biomass smoke versus cigarette smoke on inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018 Apr 18;13:1261-1267.
(36) Luttmann-Gibson H, Sarnat SE, Suh HH, Coull BA, Schwartz J, Zanobetti A, Gold DR. Short-term effects of air pollution on oxygen saturation in a cohort of senior adults in Steubenville, Ohio. J Occup Environ Med. 2014 Feb;56(2):149-54.
(37) Ramirez-Venegas A, Sansores RH, Perez-Padilla R, Regalado J, Velazquez A, Sanchez C, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006; 173:393-7.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
